1 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 17788163 | Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Jun 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial